Loading clinical trials...
Loading clinical trials...
An Observational Study to Evaluate the Effects of Twynsta Tablets (Telmisartan and Amlodipine FDC, q.d.) With Life Style Modifications on Blood Pressure, Quality of Life, and Other Risk Factors in Korean Patients With Hypertension
Conditions
Interventions
Telmisartan
amlodipine
Locations
55
South Korea
Boehringer Ingelheim Investigational Site 15
Busan, South Korea
Boehringer Ingelheim Investigational Site 37
Busan, South Korea
Boehringer Ingelheim Investigational Site 42
Busan, South Korea
Boehringer Ingelheim Investigational Site 55
Busan, South Korea
Boehringer Ingelheim Investigational Site 54
Chonbuk, South Korea
Boehringer Ingelheim Investigational Site 18
Chonnam, South Korea
Start Date
March 1, 2011
Primary Completion Date
June 1, 2014
Completion Date
June 1, 2014
Last Updated
September 21, 2015
NCT02417740
NCT07480265
NCT07073820
NCT06876233
NCT06062394
NCT06899815
Lead Sponsor
Boehringer Ingelheim
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions